A University of Cincinnati (UC)-led research team has found that generic formulations of tacrolimus, a drug used post-transplant to lower the risk of organ rejection, are just as good as the name-brand version. The findings were presented Sunday, May 3rd 2105 at the American Transplant Congress annual meeting in Philadelphia by lead investigator Rita Alloway,… Continue reading Generic Transplant Drugs as Good as Brand Name